المؤلفون: JG Berdeja, AY Krishnan, A Oriol, NWV Donk, P Rodríguez-Otero, E Askari, M Mateos, MC Minnema, LJ Costa, R Verona, BW Hilderq, S Girgisq, T Prior, JS Russell, JD Goldberg, A Chari

المصدر: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S215-S216 (2021)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137921005125; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/d752b36965e449ab9c5a34f0a12d8535

المؤلفون: Plesner T, Ht, Arkenau, Gimsing P, Jakub Krejcik, Lemech C, Mc, Minnema, Lassen U, Jp, Laubach, Palumbo A, Lisby S, Basse L, Wang J, Ak, Sasser, Me, Guckert, de Boer C, Nz, Khokhar, Yeh H, Pl, Clemens, Ahmadi T, Hm, Lokhorst

المصدر: Europe PubMed Central

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4b384af9be7a88a358faa334443b176b
http://europepmc.org/abstract/med/27531679

المؤلفون: van Meerten T; Department of Haematology, University Medical Center Groningen Groningen, The Netherlands., Kuruvilla J; Princess Margaret Cancer Centre Toronto, ON, Canada., Song KW; Vancouver General Hospital, BC Cancer, The University of British Columbia Vancouver, BC, Canada., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hemato-Oncology, Hôpital Saint-Louis, Paris University Paris, France., Minnema MC; Department of Haematology, University Medical Center Utrecht Utrecht, The Netherlands., Forcade E; CHU Bordeaux, Service d'Hematologie et Thérapie Cellulaire Bordeaux, France., De Guibert S; Hématologie Clinique, CHU Rennes Rennes, France., Kersten MJ; Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam Amsterdam, The Netherlands., Mutsaers PG; Department of Hematology, Erasmus University Medical Center Rotterdam, The Netherlands., Wermke M; TU Dresden Medizinische Fakultät Carl-Gustav Carus, NCT/UCC Early Clinical Trial Unit/Medizinische Klinik I Dresden, Germany., Zheng Y; Kite, a Gilead Company Santa Monica, CA, USA., Xue A; Kite, a Gilead Company Santa Monica, CA, USA., Winters JN; Kite, a Gilead Company Santa Monica, CA, USA., Nater J; Kite, a Gilead Company Santa Monica, CA, USA., Shen RR; Kite, a Gilead Company Santa Monica, CA, USA., Spooner C; Kite, a Gilead Company Santa Monica, CA, USA., Neumann F; Kite, a Gilead Company Santa Monica, CA, USA., Kim JJ; Kite, a Gilead Company Santa Monica, CA, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg Würzburg, Germany.

المصدر: American journal of cancer research [Am J Cancer Res] 2024 Jun 15; Vol. 14 (6), pp. 2905-2920. Date of Electronic Publication: 2024 Jun 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE

المؤلفون: Braun A; City of Hope National Medical Center, Duarte, CA., Gouni S; MD Anderson Comprehensive Cancer Center, Houston, TX., Pulles A; Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, the Netherlands., Strati P; MD Anderson Comprehensive Cancer Center, Houston, TX., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Budde LE; City of Hope National Medical Center, Duarte, CA.

المصدر: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2024 Jun; Vol. 44 (3), pp. e433516.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/therapeutic use , Multiple Myeloma*/drug therapy , Multiple Myeloma*/immunology, Humans ; Lymphoma/drug therapy ; Lymphoma/immunology ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects

المؤلفون: Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands., Yin X; Medidata Solutions, New York, NY, USA., Davi R; Medidata Solutions, New York, NY, USA., Keeping S; PRECISIONheor, Vancouver, Canada., Park JE; PRECISIONheor, Vancouver, Canada., Itani T; Kite, a Gilead Company, Santa Monica, CA, USA., Hadjivassileva T; Kite, a Gilead Company, Santa Monica, CA, USA., Castaigne JG; Kite, a Gilead Company, Santa Monica, CA, USA., Damico Khalid R; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Wu JJ; Kite, a Gilead Company, Santa Monica, CA, USA., Shah BD; Moffitt Cancer Center, Tampa, FL, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 May 24, pp. 1-10. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

المؤلفون: Jaccard A; CHU Limoges, National Amyloidosis Center and Hematology Unit, Limoges, France., Bridoux F; CHU Poitiers, Nephrology Unit, Poitiers, France., Roeloffzen W; Amyloidosis Centre of Expertise Department of Internal Medicine, Faculty of Medical Sciences, University Medical Center Groningen, Groningen, Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Bergantim R; Department of Hematology, Hospital São João, Porto, Portugal., Hájek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., João C; Department of Hematology, Hospital Clinic, IDIBAPS, Champalimaud Center for the Unknown, Lisbon, Portugal., Cibeira MT; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain., Palladini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Schönland S; Medical Department V, Amyloidosis Center Heidelberg, University of Heidelberg, Heidelberg, Germany., Merlini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Milani P; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Ravichandran S; National Amyloidosis Centre, University College London, London, United Kingdom., Hegenbart U; CHU Poitiers, Nephrology Unit, Poitiers, France., Agis H; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University Vienna, Vienna, Austria., Gros B; Janssen-Cilag S.A., Madrid, Spain., Asra A; Janssen-Cilag, London, United Kingdom., Magarotto V; MD Janssen-Cilag, Rome, Italy., Cheliotis G; Health Data Specialists, Dublin, Ireland., Psarros G; Health Data Specialists, Dublin, Ireland., Sonneveld P; Erasmus University Medical Center, Rotterdam, Netherlands., Wechalekar A; National Amyloidosis Centre, University College London, London, United Kingdom., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: ekastritis@gmail.com.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 May; Vol. 24 (5), pp. e205-e216. Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin Light-chain Amyloidosis*/therapy , Immunoglobulin Light-chain Amyloidosis*/economics , Cost of Illness*, Humans ; Retrospective Studies ; Male ; Female ; Aged ; Europe ; Middle Aged ; Health Resources/statistics & numerical data ; Health Resources/economics ; Patient Acceptance of Health Care/statistics & numerical data ; Health Care Costs/statistics & numerical data ; Aged, 80 and over

المؤلفون: Tam CS; Department of Haematology, Alfred Hospital and Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Opat S; Department of Haematology, Monash Health and Monash University, Clayton, VIC, Australia., D'Sa S; Centre for Waldenström's Macroglobulinemia and Associated Disorders, University College London Hospital Foundation Trust, London, United Kingdom., Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland., Lee HP; Department of Haematology, Flinders Medical Centre, Adelaide, SA, Australia., Cull G; Department of Haematology, Sir Charles Gairdner Hospital, University of Western Australia, Perth, WA, Australia., Owen RG; Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom., Marlton P; Department of Haematology, Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia., Wahlin BE; Department of Hematology, Karolinska Universitetssjukhuset and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., García-Sanz R; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain., McCarthy H; Department of Haematology, Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom., Mulligan S; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia., Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Castillo JJ; Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA., Czyż J; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Fernández De Larrea C; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Belada D; Department of Internal Medicine - Haematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic., Libby E; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Matous J; Colorado Blood Cancer Institute, Denver, CO., Motta M; Department of Hematology, AO Spedali Civili di Brescia, Lombardia, Italy., Siddiqi T; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Tani M; U.O. Ematologia, Dipartimento Oncologia e Ematologia, Ospedale Civile Santa Maria delle Croci, AUSL Ravenna, Italy., Trněný M; Všeobecná fakultní nemocnice v Praze, Prague, Czechia., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Buske C; Comprehensive Cancer Center Ulm, Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany., Leblond V; Service d'Hématologie Clinique, Sorbonne University, Pitié Salpêtrière Hospital, Paris, France., Treon SP; Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA., Trotman J; Department of Hematology, Concord Repatriation General Hospital, Sydney, NSW, Australia., Wu B; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Yu Y; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Shen Z; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Chan WY; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Schneider J; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Allewelt H; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Cohen A; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

المصدر: Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1639-1650.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Waldenstrom Macroglobulinemia*/drug therapy , Waldenstrom Macroglobulinemia*/genetics , Piperidines* , Pyrazoles* , Pyrimidines*, Adenine/*analogs & derivatives, Humans ; Myeloid Differentiation Factor 88/genetics ; Biomarkers

المؤلفون: Bromberg JEC; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Issa S; Department of Hematology, Middlemore Hospital, Auckland, New Zealand., van der Holt B; HOVON Foundation, Rotterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Meulen M; Department of Neurology, Medisch Spectrum Twente, Enschede, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, The Netherlands., Seute T; Department of Neurology, University Medical Center, Utrecht, The Netherlands., Durian M; Department of Hematology, ETZ Hospital, Tilburg, The Netherlands., Cull G; Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.; Department of Hematology, University of Western Australia, Crawley, Western Australia, Australia., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, VUMC, Amsterdam, The Netherlands., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nijland M; Department of Hematology, UMCG, Groningen, The Netherlands., Mason KD; Department of Hematology, Royal Melbourne Hospital, Melbourne, Australia., Beeker A; Department of Hematology, Spaarne Gasthuis, Haarlem, The Netherlands., Abrahamse-Testroote MCJ; HOVON Foundation, Rotterdam, The Netherlands., van den Bent MJ; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Jong D; Department of Pathology and HOVON Pathology, Facility and Biobank, Amsterdam UMC, VUMC, Amsterdam, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Apr 05; Vol. 26 (4), pp. 724-734.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms*/pathology , Lymphoma*/therapy, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carmustine/therapeutic use ; Cytarabine/therapeutic use ; Methotrexate/therapeutic use ; Prednisolone/therapeutic use ; Quality of Life ; Rituximab/therapeutic use ; Teniposide/therapeutic use ; Middle Aged ; Adolescent ; Young Adult ; Adult ; Aged

المؤلفون: Gant CM; Internal Medicine/Nephrology, Meander Medical Centre, Amersfoort, The Netherlands. Electronic address: c.m.gant@umcutrecht.nl., Koelman CA; Laboratory Medical Immunology, Meander Medical Centre, Amersfoort, The Netherlands., Nguyen TQ; Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands., Abrahams AC; Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands., Wetzels JFM; Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands., Duineveld C; Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands., Jak M; Hematology, University Medical Centre Utrecht, Utrecht, The Netherlands., Minnema MC; Hematology, University Medical Centre Utrecht, Utrecht, The Netherlands., Klein SK; Hematology, University Medical Centre Groningen, Groningen, The Netherlands., Jacobs JFM; Laboratory Medical Immunology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bosma RJ; Internal Medicine/Nephrology, Meander Medical Centre, Amersfoort, The Netherlands.

المصدر: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2024 Mar; Vol. 83 (3), pp. 415-419. Date of Electronic Publication: 2023 Sep 19.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6838 (Electronic) Linking ISSN: 02726386 NLM ISO Abbreviation: Am J Kidney Dis Subsets: MEDLINE

مواضيع طبية MeSH: Paraproteinemias*/complications , Paraproteinemias*/therapy , Glomerulonephritis* , Vasculitis* , Cryoglobulinemia*, Female ; Humans ; Adult ; Fibrinogen

SCR Disease Name: Cryofibrinogenemia

المؤلفون: Schulpen M; Princess Máxima Center for pediatric oncology, Utrecht., Beishuizen A; Princess Máxima Center for pediatric oncology, Utrecht., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, location VU, Amsterdam., Dinmohamed AG; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, location VU, Amsterdam, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam., Meyer-Wentrup FAG; Princess Máxima Center for pediatric oncology, Utrecht., Vormoor HJ; Princess Máxima Center for pediatric oncology, Utrecht, The Netherlands; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht., Van der Wagen LE; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht., Loeffen JLC; Princess Máxima Center for pediatric oncology, Utrecht., Karim-Kos HE; Princess Máxima Center for pediatric oncology, Utrecht, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht. h.e.karim-kos@prinsesmaximacentrum.nl.

المصدر: Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 936-941. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Non-Hodgkin*/epidemiology, Child ; Adolescent ; Humans ; Young Adult ; Netherlands/epidemiology